Nanoparticulate Olmesartan Medoxomil compositions, process for the preparation thereof and pharmaceutical compositions containing them
The present invention is directed to nanostructured (nanoparticulated) Olmesartan or its pharmaceutically acceptable ester, preferable Olmesartan Medoxomil, or co-crystal compositions, process for the preparation thereof and pharmaceutical compositions containing them. The nanoparticles of Olmesarta...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
09.02.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention is directed to nanostructured (nanoparticulated) Olmesartan or its pharmaceutically acceptable ester, preferable Olmesartan Medoxomil, or co-crystal compositions, process for the preparation thereof and pharmaceutical compositions containing them. The nanoparticles of Olmesartan or its pharmaceutically acceptable ester, preferable Olmesartan Medoxomil, or co-crystal according to the invention have an average particle size of less than about 500 nm. Olmesartan Medoxomil is an angiotensin II receptor antagonist used to treat high blood pressure. The prodrug Olmesartan Medoxomil is marketed worldwide by Daiichi Sankyo, Ltd. and in the United States by Daiichi Sankyo, Inc. |
---|---|
AbstractList | The present invention is directed to nanostructured (nanoparticulated) Olmesartan or its pharmaceutically acceptable ester, preferable Olmesartan Medoxomil, or co-crystal compositions, process for the preparation thereof and pharmaceutical compositions containing them. The nanoparticles of Olmesartan or its pharmaceutically acceptable ester, preferable Olmesartan Medoxomil, or co-crystal according to the invention have an average particle size of less than about 500 nm. Olmesartan Medoxomil is an angiotensin II receptor antagonist used to treat high blood pressure. The prodrug Olmesartan Medoxomil is marketed worldwide by Daiichi Sankyo, Ltd. and in the United States by Daiichi Sankyo, Inc. |
Author | FILIPCSEI, GENOVEVA DARVAS, FERENC OTVOS, ZSOLT PONGRACZ, KATALIN |
Author_xml | – fullname: PONGRACZ, KATALIN – fullname: FILIPCSEI, GENOVEVA – fullname: OTVOS, ZSOLT – fullname: DARVAS, FERENC |
BookMark | eNqNjL0KAjEQhFNo4d87LNgqmBPtD1Fs1EbrY7nb8wLJbkhy4BP43ObAxs5q-JiZb6pGLEwT9b4ii8eQTN1bTAQ36yhmRoYLNfISZyzU4rxEk4xwXIEPUlOM0EqA1FFmygYc2oEDSQvIDfgOg8Oa-izHX0kGTmjY8HO4uLkat2gjLb45U8vT8X44r8lLRdFnC1Oqykex0Ztir3dal3r73-oDD4tP0A |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | AU2010261511A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_AU2010261511A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 12:56:47 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_AU2010261511A13 |
Notes | Application Number: AU20100261511 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120209&DB=EPODOC&CC=AU&NR=2010261511A1 |
ParticipantIDs | epo_espacenet_AU2010261511A1 |
PublicationCentury | 2000 |
PublicationDate | 20120209 |
PublicationDateYYYYMMDD | 2012-02-09 |
PublicationDate_xml | – month: 02 year: 2012 text: 20120209 day: 09 |
PublicationDecade | 2010 |
PublicationYear | 2012 |
RelatedCompanies | DRUGGABILITY TECHNOLOGIES IP HOLDCO (JERSEY) LIMITED |
RelatedCompanies_xml | – name: DRUGGABILITY TECHNOLOGIES IP HOLDCO (JERSEY) LIMITED |
Score | 2.8417115 |
Snippet | The present invention is directed to nanostructured (nanoparticulated) Olmesartan or its pharmaceutically acceptable ester, preferable Olmesartan Medoxomil, or... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | Nanoparticulate Olmesartan Medoxomil compositions, process for the preparation thereof and pharmaceutical compositions containing them |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120209&DB=EPODOC&locale=&CC=AU&NR=2010261511A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIDSJ4vrp_ZhyNauDGHrkE32NlKb4GBLy1bRv8C_20u6an3ZWy7hDpJwubvkdxeA27jFY4MmVLcYs3Qbm7pHXaZz7lKKLoVlOzLfeTB0-xP7eepMa7Aoc2FUndBPVRwRNeoN9T1X53X2d4kVKGzl-j6eY1f6FI7bgbaJjg0M5VueFnTbvVEURL7m-xhJasMX9ehrSuttdDBW2kFH-kECwHqvXZmXklWNSngIuyOUJ_IjqDHRgH2__HutAXuDzZM3Njfatz6GbzwKMcZdqXoZyEoimU6ANBUEGdKvdDlfEAkSL5FYdyQrEgEI-qYEfT2kWVHtOxWSXrGUEyoSkr1X77b_CSESzl58JCFZlidwE_bGfl_HCc1-12_WmVRnb51CXaSCnQExk9hhZmLZ1KA2p6Znuo8Jd2KGu0Rdl59Dc5uki-3Dl3Agd0RBnL0m1PPVB7tCC57H12rhfwB_jaTh |
link.rule.ids | 230,309,783,888,25578,76884 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbosYP1CaaPbnIPsMeiIENMpWvGDC8kc61kQS6BWb0L_Dv9tqB4gtvvS13SXu53v3auyvAbVTlkUFjqluMWbqNQ92jLtM5dynFkMKyHVnv3O254ch-GjvjAszWtTCqT-inao6IFvWG9p6p_Tr9O8QKVG7l8j6a4qfkoT2sB9oKHRsI5aueFjTrrUE_6Pua7yOS1Hov6tLXlN7baCBW2sEguyY77bdem7IuJd10Ku0D2B2gPJEdQoGJMpT89dtrZdjrrq68cbiyvuURfONWiBh3ofplICvpy3ICpKkgyJB8JfPpjMgk8XUm1h1J80IAgrEpwVgPaZZ3-06EpBcs4YSKmKTvm2fb_4QQmc6ePyQhWebHcNNuDf1QxwlNftdv0hhtzt46gaJIBDsFYsaRw8zYsqlBbU5Nz3RrMXcihlqirsvPoLJN0vn239dQCofdzqTz2Hu-gH2pHZXu7FWgmC0-2CV68yy6Ukr4AWS9p9E |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Nanoparticulate+Olmesartan+Medoxomil+compositions%2C+process+for+the+preparation+thereof+and+pharmaceutical+compositions+containing+them&rft.inventor=PONGRACZ%2C+KATALIN&rft.inventor=FILIPCSEI%2C+GENOVEVA&rft.inventor=OTVOS%2C+ZSOLT&rft.inventor=DARVAS%2C+FERENC&rft.date=2012-02-09&rft.externalDBID=A1&rft.externalDocID=AU2010261511A1 |